-
Mashup Score: 2Acute SGLT-2i treatment improves cardiac efficiency during myocardial ischemia independent of Na+/H+ exchanger-1 - 2 year(s) ago
Sodium glucose co-transporter 2 inhibitors (SGLT2i) demonstrate cardioprotective benefits independent of a glucose lowering effect including preservat…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet
SGLT2i have been shown to improve cardiac outcomes in patient including reducing #MI incidence and ☠️ #SGLT2i therapies can confer #cardioprotection with as little as 15 min exposure, making metabolic drivers #Flozinates #HeartFailure https://t.co/sBRAeec9ti @IJCardio https://t.co/SlFaeEY9he